Causes and Pathophysiology of Heart Failure with Preserved Ejection Fraction

Heart Failure Clinics

Volumn 10, Issue 3, 2014, Pages 389-398

  Kovács, Árpád ^a   Papp, Zoltán ^a   Nagy, László ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Comorbidities; Exercise intolerance; Heart failure with preserved ejection fraction; Myocardial stiffness; Ventricular arterial uncoupling

Indexed keywords

CALCIUM ION; COLLAGEN; CONNECTIN;

ARTERIAL STIFFNESS; CHRONOTROPISM; COMORBIDITY; DIASTOLIC DYSFUNCTION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HUMAN; MYOFILAMENT; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SYSTOLIC DYSFUNCTION; VASCULARIZATION; AGE DISTRIBUTION; AGED; AORTIC VALVE STENOSIS; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HEART STROKE VOLUME; MIDDLE AGED; OBESITY; PHYSIOLOGY; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SEX RATIO; SURVIVAL; SYNDROME;

AGE DISTRIBUTION; AGED; AORTIC VALVE STENOSIS; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART FAILURE, DIASTOLIC; HEART FAILURE, SYSTOLIC; HUMANS; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; SEX DISTRIBUTION; STROKE VOLUME; SURVIVAL ANALYSIS; SYNDROME; VASCULAR STIFFNESS;

EID: 84903479283     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2014.04.002     Document Type: Review

References (71)

1. Owan T.E., Hodge D.O., Herges R.M., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. NEngl J Med 2006, 355:251-259.
2. Zile M.R., Gottdiener J.S., Hetzel S.J., et al. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 2011, 124:2491-2501.
3. Velagaleti R.S., Gona P., Pencina M.J., et al. Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. Am J Cardiol 2014, 113:117-122.
4. Shah A.M. Ventricular remodeling in heart failure with preserved ejection fraction. Curr Heart Fail Rep 2013, 10:341-349.
5. Borbely A., Papp Z., Edes I., et al. Molecular determinants of heart failure with normal left ventricular ejection fraction. Pharmacol Rep 2009, 61:139-145.
6. Borlaug B.A., Nishimura R.A., Sorajja P., et al. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010, 3:588-595.
7. Banerjee P., Clark A.L., Nikitin N., et al. Diastolic heart failure. Paroxysmal or chronic?. Eur J Heart Fail 2004, 6:427-431.
8. Schwartzenberg S., Redfield M.M., From A.M., et al. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. JAm Coll Cardiol 2012, 59:442-451.
9. Antonini-Canterin F., Carerj S., Di Bello V., et al. Arterial stiffness and ventricular stiffness: a couple of diseases or a coupling disease? A review from the cardiologist's point of view. Eur J Echocardiogr 2009, 10(1):36-43.
10. Frenneaux M., Williams L. Ventricular-arterial and ventricular-ventricular interactions and their relevance to diastolic filling. Prog Cardiovasc Dis 2007, 49:252-262.
11. O'Rourke M.F., Yaginuma T., Avolio A.P. Physiological and pathophysiological implications of ventricular/vascular coupling. Ann Biomed Eng 1984, 12:119-134.
12. Goto T., Ohte N., Fukuta H., et al. Relationship between effective arterial elastance, total vascular resistance, and augmentation index at the ascending aorta and left ventricular diastolic function in older women. Circ J 2013, 77:123-129.
13. Dong S.J., Hees P.S., Huang W.M., et al. Independent effects of preload, afterload, and contractility on left ventricular torsion. Am J Physiol 1999, 277(3Pt 2):H1053-H1060.
14. Starling M.R. Left ventricular-arterial coupling relations in the normal human heart. Am Heart J 1993, 125:1659-1666.
15. Sunagawa K., Maughan W.L., Sagawa K. Optimal arterial resistance for the maximal stroke work studied in isolated canine left ventricle. Circ Res 1985, 56:586-595.
16. Chantler P.D., Lakatta E.G., Najjar S.S. Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. JAppl Physiol (1985) 2008, 105:1342-1351.
17. De Tombe P.P., Jones S., Burkhoff D., et al. Ventricular stroke work and efficiency both remain nearly optimal despite altered vascular loading. Am J Physiol 1993, 264:H1817-H1824.
18. Redfield M.M., Jacobsen S.J., Borlaug B.A., et al. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation 2005, 112:2254-2262.
19. Chantler P.D., Lakatta E.G. Arterial-ventricular coupling with aging and disease. Front Physiol 2012, 3:90.
20. Lam C.S., Roger V.L., Rodeheffer R.J., et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 2007, 115(15):1982-1990.
21. Phan T.T., Abozguia K., Nallur Shivu G., et al. Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency. JAm Coll Cardiol 2009, 54:402-409.
22. Gillebert T.C., De Buyzere M.L. HFpEF, diastolic suction, and exercise. JACC Cardiovasc Imaging 2012, 5:871-873.
23. Tan Y.T., Wenzelburger F., Lee E., et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. JAm Coll Cardiol 2009, 54:36-46.
24. Borlaug B.A., Jaber W.A., Ommen S.R., et al. Diastolic relaxation and compliance reserve during dynamic exercise in heart failure with preserved ejection fraction. Heart 2011, 97:964-969.
25. Kawaguchi M., Hay I., Fetics B., et al. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation 2003, 107:714-720.
26. Sohn D.W., Chai I.H., Lee D.J., et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. JAm Coll Cardiol 1997, 30:474-480.
27. Park J.H., Marwick T.H. Use and limitations of E/e' to assess left ventricular filling pressure by echocardiography. JCardiovasc Ultrasound 2011, 19:169-173.
28. Ha J.W., Oh J.K., Pellikka P.A., et al. Diastolic stress echocardiography: a novel noninvasive diagnostic test for diastolic dysfunction using supine bicycle exercise Doppler echocardiography. JAm Soc Echocardiogr 2005, 18:63-68.
29. Paulus W.J., Tschope C., Sanderson J.E., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007, 28(20):2539-2550.
30. Kitzman D.W., Higginbotham M.B., Cobb F.R., et al. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. JAm Coll Cardiol 1991, 17:1065-1072.
31. Zile M.R., Kjellstrom B., Bennett T., et al. Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction. Circ Heart Fail 2013, 6:508-516.
32. Zile M.R., Baicu C.F., Gaasch W.H. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. NEngl J Med 2004, 350:1953-1959.
33. Ohara T., Niebel C.L., Stewart K.C., et al. Loss of adrenergic augmentation of diastolic intra-LV pressure difference in patients with diastolic dysfunction: evaluation by color M-mode echocardiography. JACC Cardiovasc Imaging 2012, 5:861-870.
34. Abudiab M.M., Redfield M.M., Melenovsky V., et al. Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail 2013, 15:776-785.
35. Borlaug B.A., Lam C.S., Roger V.L., et al. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. JAm Coll Cardiol 2009, 54:410-418.
36. Borlaug B.A., Kass D.A. Ventricular-vascular interaction in heart failure. Heart Fail Clin 2008, 4:23-36.
37. Borlaug B.A., Melenovsky V., Russell S.D., et al. Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation 2006, 114:2138-2147.
38. Phan T.T., Shivu G.N., Abozguia K., et al. Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction. Circ Heart Fail 2010, 3:29-34.
39. Tartiere-Kesri L., Tartiere J.M., Logeart D., et al. Increased proximal arterial stiffness and cardiac response with moderate exercise in patients with heart failure and preserved ejection fraction. JAm Coll Cardiol 2012, 59:455-461.
40. Haykowsky M.J., Liang Y., Pechter D., et al. Ameta-analysis of the effect of exercise training on left ventricular remodeling in heart failure patients: the benefit depends on the type of training performed. JAm Coll Cardiol 2007, 49:2329-2336.
41. Matsue Y., Suzuki M., Nagahori W., et al. Endothelial dysfunction measured by peripheral arterial tonometry predicts prognosis in patients with heart failure with preserved ejection fraction. Int J Cardiol 2013, 168:36-40.
42. Akiyama E., Sugiyama S., Matsuzawa Y., et al. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. JAm Coll Cardiol 2012, 60:1778-1786.
43. Nichols W.W., Edwards D.G. Arterial elastance and wave reflection augmentation of systolic blood pressure: deleterious effects and implications for therapy. JCardiovasc Pharmacol Ther 2001, 6:5-21.
44. Weber T., O'Rourke M.F., Ammer M., et al. Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction. Am J Hypertens 2008, 21:1194-1202.
45. Abramov D., He K.L., Wang J., et al. The impact of extra cardiac comorbidities on pressure volume relations in heart failure and preserved ejection fraction. JCard Fail 2011, 17:547-555.
46. Mohammed S.F., Borlaug B.A., Roger V.L., et al. Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail 2012, 5:710-719.
47. Edelmann F., Stahrenberg R., Gelbrich G., et al. Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. Clin Res Cardiol 2011, 100:755-764.
48. Shah S.J., Gheorghiade M. Heart failure with preserved ejection fraction: treat now by treating comorbidities. JAMA 2008, 300:431-433.
49. Pieske B. Heart failure with preserved ejection fraction-a growing epidemic or 'The Emperor's New Clothes?'. Eur J Heart Fail 2011, 13:11-13.
50. Paulus W.J., Tschope C. Anovel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. JAm Coll Cardiol 2013, 62:263-271.
51. Linke W.A., Kruger M. The giant protein titin as an integrator of myocyte signaling pathways. Physiology (Bethesda) 2010, 25:186-198.
52. Borbely A., van der Velden J., Papp Z., et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005, 111:774-781.
53. van Heerebeek L., Borbely A., Niessen H.W., et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006, 113:1966-1973.
54. Hamdani N., Bishu K.G., von Frieling-Salewsky M., et al. Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction. Cardiovasc Res 2013, 97:464-471.
55. van Heerebeek L., Hamdani N., Falcao-Pires I., et al. Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 2012, 126:830-839.
56. Falcao-Pires I., Hamdani N., Borbely A., et al. Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness. Circulation 2011, 124:1151-1159.
57. van Heerebeek L., Hamdani N., Handoko M.L., et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008, 117:43-51.
58. Querejeta R., Lopez B., Gonzalez A., et al. Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis. Circulation 2004, 110:1263-1268.
59. Gonzalez A., Lopez B., Querejeta R., et al. Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction. Hypertension 2010, 55:1418-1424.
60. Westermann D., Lindner D., Kasner M., et al. Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 2011, 4:44-52.
61. Carrier L., Schlossarek S., Willis M.S., et al. The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. Cardiovasc Res 2010, 85:330-338.
62. Ho C.Y., Lopez B., Coelho-Filho O.R., et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. NEngl J Med 2010, 363:552-563.
63. Chaturvedi R.R., Herron T., Simmons R., et al. Passive stiffness of myocardium from congenital heart disease and implications for diastole. Circulation 2010, 121:979-988.
64. Silberman G.A., Fan T.H., Liu H., et al. Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction. Circulation 2010, 121:519-528.
65. Periasamy M., Janssen P.M. Molecular basis of diastolic dysfunction. Heart Fail Clin 2008, 4:13-21.
66. Dupont S., Maizel J., Mentaverri R., et al. The onset of left ventricular diastolic dysfunction in SHR rats is not related to hypertrophy or hypertension. Am J Physiol Heart Circ Physiol 2012, 302:H1524-H1532.
67. Shao C.H., Capek H.L., Patel K.P., et al. Carbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetes. Diabetes 2011, 60:947-959.
68. Louch W.E., Hougen K., Mork H.K., et al. Sodium accumulation promotes diastolic dysfunction in end-stage heart failure following Serca2 knockout. JPhysiol 2010, 588:465-478.
69. Fischer T.H., Maier L.S., Sossalla S. The ryanodine receptor leak: how a tattered receptor plunges the failing heart into crisis. Heart Fail Rev 2013, 18:475-483.
70. Sossalla S., Wagner S., Rasenack E.C., et al. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts-role of late sodium current and intracellular ion accumulation. JMol Cell Cardiol 2008, 45:32-43.
71. Papp Z., Borbely A., Paulus W.J. CrossTalk opposing view: the late sodium current is not an important player in the development of diastolic heart failure (heart failure with a preserved ejection fraction). JPhysiol 2014, 592(Pt 3):415-417.